Contact Information
7260 OByrnes Ferry Road , Copperopolis, California 95228, United States
Detailed Information
Lakes Treatment Center Inc
-
Services:
- Other contracted prescribing entity
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Buprenorphine detoxification
- Prescribes naltrexone
- Maintenance service with medically supervised withdrawal after stabilization
- Buprenorphine maintenance
- Use methadone/buprenorphine for pain management or emergency dosing
- Accepts clients using MAT but prescribed elsewhere
- Lofexidine or Clonidine detoxification
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Outcome follow-up after discharge
- Discharge Planning
- Naloxone and overdose education
- Aftercare/continuing care
- Female
- Male
- Other contracted prescribing entity
- Self-help groups
- Mentoring/peer support
- Housing services
- Employment counseling or training
- Assistance with obtaining social services
- Long-term residential
- Residential detoxification
- Short-term residential
- Residential/24-hour residential
- Smoking permitted in designated area
- Mental health services
- Case management service
- Social skills development
- Suicide prevention services
- Domestic violence services, including family or partner
- Transportation assistance
- Early intervention for HIV
- Integrated primary care services
- Methamphetamines detoxification
- Cocaine Detoxification
- Medication routinely used during detoxification
- Opioids detoxification
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Treatment for gambling disorder
- Treatment for other addiction disorder
- Health education services other than HIV/AIDS or hepatitis
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- HIV or AIDS education, counseling, or support
- Substance use disorder education
- Group counseling
- Hepatitis education, counseling, or support
- Marital/couples counseling
- Smoking/vaping/tobacco cessation counseling
- Family counseling
- Individual counseling
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Clients who have experienced sexual abuse
- Pregnant/postpartum women
- Clients who have experienced intimate partner violence, domestic violence
- Clients who have experienced trauma
- Clients with co-occurring mental and substance use disorders
- Young adults
- Adult women
- Seniors or older adults
- Clients with co-occurring pain and substance use disorders
- Adult men
- Criminal justice (other than DUI/DWI)/Forensic clients
- Adults
- Young Adults
- IHS/Tribal/Urban (ITU) funds
- Cash or self-payment
- Private health insurance
- Comprehensive mental health assessment
- Outreach to persons in the community
- Comprehensive substance use assessment
- Complete medical history/physical exam
- Screening for substance use
- Screening for mental disorders
- Screening for tobacco use
- Private for-profit organization
- Drug Enforcement Agency (DEA)
- State department of health
- State Substance use treatment agency
- The Joint Commission
- Substance use disorder counseling
- 12-step facilitation
- Trauma-related counseling
- Contingency management/motivational incentives
- Cognitive behavioral therapy
- Matrix Model
- Relapse prevention
- Anger management
- Telemedicine/telehealth therapy
- Motivational interviewing
- Vaping permitted in designated area
- Non-nicotine smoking/tobacco cessation
- Buprenorphine with naloxone
- Medications for pre-exposure to prophylaxis
- Buprenorphine (extended-release, injectable)
- Acamprosate (CampralĀ®)
- Clonidine
- Medications for HIV treatment
- Nicotine replacement
- Naltrexone (extended-release, injectable)
- Naltrexone (oral)
- Buprenorphine without naloxone
- Medications for Hepatitis C treatment
- Buprenorphine sub-dermal implant
- Lofexidine
- Medication for mental disorders
- Drug or alcohol urine screening
- STD testing
- Testing for Hepatitis C (HCV)
- HIV testing
- Drug and alcohol oral fluid testing
- TB screening
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis B (HBV)
- Metabolic syndrome monitoring
External Source of Medications Used for Alcohol Use Disorder Treatment
Opioid Medications used in Treatment
Type of Opioid Treatment
Type of Alcohol Use Disorder Treatment
Transitional Services
Gender Accepted
External Opioid Medications Source
Recovery Support Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Facility Smoking Policy
Ancillary Services
Detoxification (medical withdrawal) Services
Other Services
Education and Counseling Services
Type of Care
Special Programs/Groups Offered
Age Groups Accepted
Payment/Insurance/Funding Accepted
Assessment/Pre-treatment
Facility Operation (e.g., Private, Public)
License/Certification/Accreditation
Treatment Approaches
Facility Vaping Policy
Pharmacotherapies
Testing
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm